These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9275421)

  • 41. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
    Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
    J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):169-72. PubMed ID: 15288224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cytological complications of IUDs (author's transl)].
    Saurel J; Marc J; Audebert A; Malgouyat R; Morard JL
    Arch Anat Cytol Pathol; 1982; 30(1):20-4. PubMed ID: 7082054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The IUD and endometrial bleeding.
    Rybo G
    J Reprod Med; 1978 Mar; 20(3):175-82. PubMed ID: 347075
    [No Abstract]   [Full Text] [Related]  

  • 46. [IUD-related anatomical, cytological and pathological modifications in the uterine tract (author's transl)].
    Levrier M
    Contracept Fertil Sex (Paris); 1982 May; 10(5):293-9. PubMed ID: 12338181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification of the cervical flora by IUCD.
    Blum M; David F
    Br J Sex Med; 1982 Apr; 9(83):38, 40. PubMed ID: 12264790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD.
    Yu J; Li J; Li HG; Li JX; Xie CS; Zhu CH
    Contraception; 2008 Oct; 78(4):319-23. PubMed ID: 18847581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The morphologic changes of endometrial spiral arterioles in IUD-induced menorrhagia.
    Pan JF; Yu YL; Wang LJ; Yan QH
    Adv Contracept; 1994 Sep; 10(3):213-22. PubMed ID: 7863847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoplasia with use of intrauterine devices.
    Curtis KM; Marchbanks PA; Peterson HB
    Contraception; 2007 Jun; 75(6 Suppl):S60-9. PubMed ID: 17531619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the copper intrauterine device on the expression of cyclooxygenase-1 and -2 in the endometrium.
    Xin ZM; Cao LM; Xie QZ; Sun Y; Su YC; Guo YH
    Int J Gynaecol Obstet; 2009 May; 105(2):166-8. PubMed ID: 19230888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of herb therapy for benefiting qi and removing blood stasis on ultrastructure of vascular endothelial cells and vascular smooth muscle cells of uterine endometrium in rabbits with copper intrauterine device].
    Lei L; You ZL; Fu LM; Wen LX
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):60-3. PubMed ID: 16409973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium.
    Coskun E; Cakiroglu Y; Aygun BK; Muezzinoglu B; Caliskan E
    Contraception; 2011 Dec; 84(6):637-41. PubMed ID: 22078195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Complications resulting from the insertion of contraceptive pessaries].
    Feige A
    Med Klin; 1981 Feb; 76(4):93-4. PubMed ID: 7219337
    [No Abstract]   [Full Text] [Related]  

  • 57. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA; Veldhuis HM; Lagro-Janssen TL
    Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrauterine release of progesterone. II. Modification of macromolecular synthesis of endometrium.
    Hernandez O; Ballesteros LM; Aznar R; Delgado NM; Rosado A
    Contracept Deliv Syst; 1981 Oct; 2(4):319-25. PubMed ID: 12336993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.